SE9002589L - Neutrofil-aktiverande peptid-2 - Google Patents

Neutrofil-aktiverande peptid-2

Info

Publication number
SE9002589L
SE9002589L SE9002589A SE9002589A SE9002589L SE 9002589 L SE9002589 L SE 9002589L SE 9002589 A SE9002589 A SE 9002589A SE 9002589 A SE9002589 A SE 9002589A SE 9002589 L SE9002589 L SE 9002589L
Authority
SE
Sweden
Prior art keywords
asp
tyr
leu
peptid
peptides
Prior art date
Application number
SE9002589A
Other languages
English (en)
Swedish (sv)
Other versions
SE9002589D0 (sv
Inventor
M Baggiolini
Original Assignee
Sandoz Ag
Kocher Theodor Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888828728A external-priority patent/GB8828728D0/en
Priority claimed from GB898909681A external-priority patent/GB8909681D0/en
Application filed by Sandoz Ag, Kocher Theodor Inst filed Critical Sandoz Ag
Publication of SE9002589D0 publication Critical patent/SE9002589D0/xx
Publication of SE9002589L publication Critical patent/SE9002589L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE9002589A 1988-12-08 1990-08-07 Neutrofil-aktiverande peptid-2 SE9002589L (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888828728A GB8828728D0 (en) 1988-12-08 1988-12-08 Neutrophil-stimulating activity i
GB898909681A GB8909681D0 (en) 1989-04-27 1989-04-27 Neutrophil-stimulating activity 1
PCT/EP1989/001389 WO1990006321A1 (en) 1988-12-08 1989-11-17 Neutrophil-activating peptide-2

Publications (2)

Publication Number Publication Date
SE9002589D0 SE9002589D0 (sv) 1990-08-07
SE9002589L true SE9002589L (sv) 1990-08-07

Family

ID=26294713

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9002589A SE9002589L (sv) 1988-12-08 1990-08-07 Neutrofil-aktiverande peptid-2

Country Status (19)

Country Link
US (1) US5759533A (OSRAM)
JP (1) JP3051160B2 (OSRAM)
KR (1) KR910700260A (OSRAM)
AU (1) AU634508B2 (OSRAM)
BE (1) BE1003636A4 (OSRAM)
CA (1) CA2004685A1 (OSRAM)
CH (1) CH681625A5 (OSRAM)
DK (1) DK188690A (OSRAM)
ES (1) ES2047458A6 (OSRAM)
FI (1) FI903931A0 (OSRAM)
FR (1) FR2640142B1 (OSRAM)
GB (1) GB2231872B (OSRAM)
GR (1) GR1000455B (OSRAM)
IL (1) IL92557A0 (OSRAM)
NL (1) NL8921262A (OSRAM)
NZ (1) NZ231652A (OSRAM)
PT (1) PT92509A (OSRAM)
SE (1) SE9002589L (OSRAM)
WO (1) WO1990006321A1 (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3051160B2 (ja) * 1988-12-08 2000-06-12 ノバルティス・アクチエンゲゼルシャフト 好中球活性化ペプチド‐２
US6673893B1 (en) 1990-02-01 2004-01-06 University Of South Florida Leukocyte derived growth factor 2
CA2075196A1 (en) * 1990-02-01 1991-08-02 Gary R. Grotendorst Leukocyte-derived growth factor
WO1993001826A1 (en) * 1991-07-19 1993-02-04 East Carolina University Method of treating asthma
WO1993009794A1 (en) * 1991-11-15 1993-05-27 University Of Pennsylvania Suppression of megakaryocytopoiesis by neutrophil activating peptide-2
EP0677106A4 (en) * 1993-01-07 1998-12-09 Univ South Florida GROWTH FACTORS MADE OF LEUKOCYTEN.
US5578569A (en) * 1993-03-12 1996-11-26 Tam; Cherk S. Method of increasing bone growth
US5786327A (en) 1993-03-12 1998-07-28 Gensci Regeneration Sciences Inc. Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US5912232A (en) * 1994-09-23 1999-06-15 Board Of Regents Of The University Of Nebraska Anti-inflammatory polypeptide antagonists of human I1-8
US6352973B1 (en) 1995-06-07 2002-03-05 Osteopharm Inc. Bone stimulating factor
US6117839A (en) * 1995-06-07 2000-09-12 Gensci Regeneration Sciences, Inc. Bone stimulating factor
US5880094A (en) * 1995-06-07 1999-03-09 Osteopharm Limited Polypeptides that stimulate bone growth
US6693081B2 (en) * 1995-09-26 2004-02-17 Osteopharm Inc. Bone stimulating factor
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
US6838435B1 (en) 1997-09-25 2005-01-04 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Isolated and recombinant antimicrobial peptides thrombocidin-1 (TC-1) and thrombocidin-2(TC-2) or variants thereof
GB9807721D0 (en) * 1998-04-08 1998-06-10 Chiron Spa Antigen
CA2723031C (en) * 2000-03-07 2014-05-20 Japan Tobacco Inc. Polypeptides having neutrophil stimulating activity
US6815421B1 (en) 2001-03-22 2004-11-09 Osteopharm Inc. Polypeptides for use in ameliorating effects of aging in mammals
EP1534752B1 (en) 2002-05-01 2011-08-03 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
US7177246B2 (en) * 2003-09-12 2007-02-13 Hewlett-Packard Development Company, L.P. Optical disk drive focusing apparatus using sum signal
PH12013500990A1 (en) 2010-11-19 2022-11-23 Eisai R&D Man Co Ltd Neutralizing anti-ccl20 antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897348A (en) * 1983-08-25 1990-01-30 Sri International Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof
DE3737703A1 (de) * 1987-11-06 1989-05-18 Ferring Arzneimittel Gmbh Neutrophilen aktivierendes polypeptid, verfahren zu dessen herstellung sowie dessen verwendung als arzneimittel und diagnostikum
US5026639A (en) * 1988-01-14 1991-06-25 Nippon Mining Company, Limited Method to improve mRNA translation and use thereof for production of platelet factor-4
JP3051160B2 (ja) * 1988-12-08 2000-06-12 ノバルティス・アクチエンゲゼルシャフト 好中球活性化ペプチド‐２

Also Published As

Publication number Publication date
KR910700260A (ko) 1991-03-14
SE9002589D0 (sv) 1990-08-07
BE1003636A4 (fr) 1992-05-12
GR890100810A (en) 1991-03-15
AU4655689A (en) 1990-06-26
FI903931A7 (fi) 1990-08-08
IL92557A0 (en) 1990-08-31
PT92509A (pt) 1990-06-29
CA2004685A1 (en) 1990-06-08
US5759533A (en) 1998-06-02
FR2640142B1 (fr) 1994-09-23
JPH03503767A (ja) 1991-08-22
WO1990006321A1 (en) 1990-06-14
FI903931A0 (fi) 1990-08-08
ES2047458A6 (es) 1994-02-16
DK188690D0 (da) 1990-08-07
AU634508B2 (en) 1993-02-25
DK188690A (da) 1990-08-07
GB2231872B (en) 1992-07-22
NL8921262A (nl) 1990-11-01
NZ231652A (en) 1993-02-25
FR2640142A1 (fr) 1990-06-15
GR1000455B (el) 1992-07-30
CH681625A5 (OSRAM) 1993-04-30
GB9011468D0 (en) 1990-08-29
GB2231872A (en) 1990-11-28
JP3051160B2 (ja) 2000-06-12

Similar Documents

Publication Publication Date Title
SE9002589L (sv) Neutrofil-aktiverande peptid-2
DZ467A1 (fr) Interferon immunitaire urbain.
BG60256B1 (bg) Рекомбинантен метод за получаване на лимфотоксин
DK0500785T3 (da) Humant T-celleaktivitet felint protein (TRFP) isoleret fra husstøv samt anvendelser heraf
GR3021198T3 (en) Interleukin-4 protein having bcgf and tcgf activity on human cells (human interleukin-4)
MY102472A (en) Preparation of funtional human urokinase proteins.
ATE87655T1 (de) Markierer der t-zelle aktivierung.
GB2171103B (en) Novel peptides and peptide derivatives, their preparation and use and pharmaceutical compositions containing them
HUP0100456A1 (hu) IFNAR2/IFN komplex, alkalmazásai és a komplexet tartalmazó készítmények
EP0592566A4 (en) CYSTEIN-FREE IL-6 MUTANTS.
EP0228192A3 (en) Renin-inhibitory oligopeptides, their preparation and use
ATE110742T1 (de) Peptid-verbindungen.
FI893681A0 (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
RU94045930A (ru) Белки, днк, вектор, клетка, способы получения и очистки белка, фармацевтическая композиция
IL90391A0 (en) Peptides suppressing the function of the immune system,their preparation and pharmaceutical compositions containing them
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
ATE229983T1 (de) Maspin- ein neues serpin mit tumor unterdrückender aktivität
CA2163805A1 (en) Novel activating factor of leukocytes
IL91771A0 (en) Increased expression of small molecular weight recombinant proteins
ES2052562T3 (es) Peptido antineoplasico inducido por la interleucina-2.
RU94046405A (ru) Птг-соединения и содержащий их фармацевтический состав, способ получения желаемых полипептидов, нуклеотидная последовательность, бактериальный вектор экспрессии, бактериальные хозяйские клетки и составной белок
ES2114170T3 (es) Peptidos con actividad organo-protectora, su procedimiento de preparacion y su utilizacion en la terapia.
KR910009280A (ko) 원발성 흉막암 치료용 제약 조성물의 제조에 있어서 감마 인터페론 활성을 갖는 폴리펩티드의 용도
MY103637A (en) Neutrophil-activating factor
ATE54941T1 (de) Cystein verminderte muteine von biologisch aktiven menschlichen tnf-proteinen.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9002589-1

Effective date: 19921206

Format of ref document f/p: F